Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $0.4.

  • Chemours' EPS (Weighted Average and Diluted) rose 28181.82% to $0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.22, marking a year-over-year decrease of 64146.34%. This contributed to the annual value of $0.47 for FY2024, which is 12937.5% up from last year.
  • As of Q3 2025, Chemours' EPS (Weighted Average and Diluted) stood at $0.4, which was up 28181.82% from -$2.54 recorded in Q2 2025.
  • In the past 5 years, Chemours' EPS (Weighted Average and Diluted) ranged from a high of $1.52 in Q3 2022 and a low of -$2.54 during Q2 2025
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.39 (2021), whereas its average is $0.2.
  • As far as peak fluctuations go, Chemours' EPS (Weighted Average and Diluted) soared by 116363.64% in 2021, and later plummeted by 75128.21% in 2025.
  • Over the past 5 years, Chemours' EPS (Weighted Average and Diluted) (Quarter) stood at $1.39 in 2021, then crashed by 146.76% to -$0.65 in 2022, then skyrocketed by 81.54% to -$0.12 in 2023, then soared by 58.33% to -$0.05 in 2024, then skyrocketed by 900.0% to $0.4 in 2025.
  • Its last three reported values are $0.4 in Q3 2025, -$2.54 for Q2 2025, and -$0.03 during Q1 2025.